TY - JOUR
T1 - A validation study of PHQ-9 suicide item with the Columbia Suicide Severity Rating Scale in outpatients with mood disorders at National Network of Depression Centers
AU - Chung, Tong Han
AU - Hanley, Kathleen
AU - Le, Yen Chi
AU - Merchant, Alisha
AU - Nascimento, Flavio
AU - De Figueiredo, Juliana Mendonca
AU - Wilcox, Holly C.
AU - Coryell, William H.
AU - Soares, Jair C.
AU - Selvaraj, Sudhakar
N1 - Funding Information:
This work was made possible, in part, by a research collaboration supported by the National Network of Depression Centers (NNDC), a consortium of academic medical centers united to advance research and care delivery for mood disorders. We thank the member centers and patients of the National Network of Depression Centers Mood Outcomes Program.
Funding Information:
SS has received grants/research support from NIH R21 ( 1R21MH119441-01A1 ) and SAMHSA ( 6H79FG000470-01M003 ). The SAMHSA grant-supported THC, KH, and YCL ( 6H79FG000470-01M003 ).
Publisher Copyright:
© 2022 Elsevier B.V.
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Background: In the United States, suicide is one of the serious public health problems and a major cause of death. Several researchers and clinical settings use the patient health questionnaires (PHQ-9) to gauge depression and psychological distress among adults and to predict suicide and death. This study aimed to assess the sensitivity, specificity, and predictive potential of suicide Q9 of the PHQ-9 compared to the Columbia-suicide severity rating scale (C-SSRS). Methods: Adults aged 19 or older, identified with a primary mood disorder diagnosis during their initial clinic visit between 2012 and 2020 from the National Network of Depression Centers, were included in the study. The accuracy of the PHQ-9 suicide item was compared with the gold standard, the C-SSRS. Results: Out of 2677 study participants, 31.6 % (n = 846) and 11.65 % (n = 312) had positive responses to the PHQ-9 suicide item and C-SSRS response, respectively. The sensitivity of the PHQ-9 compared to the C-SSR was 74.7 % (95%CI: 69.6 %–79.2 %), specificity 74.1 % (95%CI: 72.3 %–75.8 %), positive predictive value 27.5 % (95%CI: 24.6 %–30.6 %), and negative predictive value 95.7 % (95%CI: 94.7 %–96.5 %). The secondary analysis results showed better validity results of the PHQ-9 suicide item when compared to the suicide ideation item of the C-SSRS. Limitations: This study is among mood disorder patients so additional research would be necessary among populations with different conditions. Conclusion: For initial suicide screening, the PHQ-9 suicide item would over identify patients as at risk for suicide and the C-SSRS should be used mood disorder clinics to identify suicide risk.
AB - Background: In the United States, suicide is one of the serious public health problems and a major cause of death. Several researchers and clinical settings use the patient health questionnaires (PHQ-9) to gauge depression and psychological distress among adults and to predict suicide and death. This study aimed to assess the sensitivity, specificity, and predictive potential of suicide Q9 of the PHQ-9 compared to the Columbia-suicide severity rating scale (C-SSRS). Methods: Adults aged 19 or older, identified with a primary mood disorder diagnosis during their initial clinic visit between 2012 and 2020 from the National Network of Depression Centers, were included in the study. The accuracy of the PHQ-9 suicide item was compared with the gold standard, the C-SSRS. Results: Out of 2677 study participants, 31.6 % (n = 846) and 11.65 % (n = 312) had positive responses to the PHQ-9 suicide item and C-SSRS response, respectively. The sensitivity of the PHQ-9 compared to the C-SSR was 74.7 % (95%CI: 69.6 %–79.2 %), specificity 74.1 % (95%CI: 72.3 %–75.8 %), positive predictive value 27.5 % (95%CI: 24.6 %–30.6 %), and negative predictive value 95.7 % (95%CI: 94.7 %–96.5 %). The secondary analysis results showed better validity results of the PHQ-9 suicide item when compared to the suicide ideation item of the C-SSRS. Limitations: This study is among mood disorder patients so additional research would be necessary among populations with different conditions. Conclusion: For initial suicide screening, the PHQ-9 suicide item would over identify patients as at risk for suicide and the C-SSRS should be used mood disorder clinics to identify suicide risk.
KW - C-SSRS
KW - PHQ-9
KW - Suicide risk
KW - Validation study
UR - http://www.scopus.com/inward/record.url?scp=85139734338&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139734338&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2022.09.131
DO - 10.1016/j.jad.2022.09.131
M3 - Article
C2 - 36181915
AN - SCOPUS:85139734338
SN - 0165-0327
VL - 320
SP - 590
EP - 594
JO - Journal of Affective Disorders
JF - Journal of Affective Disorders
ER -